{"id":54071,"date":"2023-02-20T15:04:23","date_gmt":"2023-02-20T14:04:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/eurofins-companies-launch-sars-cov-2-variant-xbb-1-5-droplet-digital-pcr-assay-ddpcr-for-wastewater-surveillance\/"},"modified":"2023-02-20T15:04:23","modified_gmt":"2023-02-20T14:04:23","slug":"eurofins-companies-launch-sars-cov-2-variant-xbb-1-5-droplet-digital-pcr-assay-ddpcr-for-wastewater-surveillance","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/eurofins-companies-launch-sars-cov-2-variant-xbb-1-5-droplet-digital-pcr-assay-ddpcr-for-wastewater-surveillance\/","title":{"rendered":"Eurofins Companies Launch SARS-CoV-2 Variant XBB.1.5 Droplet Digital PCR Assay (ddPCR) for Wastewater Surveillance"},"content":{"rendered":"
\n

\nHighly sensitive ddPCR analytical tool helps identify rapidly increasing SARS-CoV-2 Variant of Concern, XBB.1.5, in wastewater samples domestically and internationally, expanding the comprehensive SARS-CoV-2 wastewater monitoring platform of the Eurofins network<\/i><\/b>\n<\/p>\n

WEST SACRAMENTO, Calif.–(BUSINESS WIRE)–Eurofins Environment Testing Northern California: Wastewater (EWW) and Eurofins Pandemic Prevention Services (EPPS) today launched a droplet digital PCR (ddPCR) assay for the quantitative analysis of SARS-CoV-2 Variant of Concern (VoC) XBB.1.5 in wastewater.\n<\/p>\n

<\/a><\/p>\n

\nThe XBB.1.5 VoC is differentiated from other SARS-CoV-2 variants currently circulating through identification of a single point mutation. This development furthers the strategic initiative of Eurofins (Paris:ERF) companies to continually monitor novel VoCs showing significant incidence within the U.S. and respond to the rapidly changing landscape of the SARS-CoV-2 pandemic.\n<\/p>\n

\nVariant XBB.1.5 currently comprises >74% of U.S. SARS-CoV-2 variant distribution and has seen a minimum 10% weekly increase in national prevalence since January 2023. The Eastern U.S. currently has a notably high presence of XBB.1.5, specifically in HHS Region 1 (93%), Region 2 (95%), and Region 3 (85%). The World Health Organization has stated that, along with BQ.1 variants, XBB variants are the most antibody-resistant SARS-CoV-2 variants to date, but do not carry any mutation known to be associated with a potential change in severity.\n<\/p>\n

\nEmpowering community leaders and stakeholders to make evidence-based decisions is central to the Eurofins wastewater surveillance offering – accomplished through robust scientific techniques, complete project development\/support, and access to teams of established industry experts in wastewater epidemiology.\n<\/p>\n

\nGovernments, public institutions, and businesses have leveraged wastewater monitoring to protect the populations they serve, Eurofins companies offer technical expertise and support to ensure their strategies and mitigation efforts remain effective.\n<\/p>\n

\nKey Features<\/b>\n<\/p>\n